Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2022 Jul 11:1–13. Online ahead of print. doi: 10.1007/s40615-022-01349-9

Estimating Excess Deaths by Race/Ethnicity in the State of California During the COVID-19 Pandemic

Amir Habibdoust 1,, Moosa Tatar 2, Fernando A Wilson 3,4,5
PMCID: PMC9273689  PMID: 35818019

Abstract

Introduction

To examine excess mortality among minorities in California during the COVID-19 pandemic.

Methods

Using seasonal autoregressive integrated moving average time series, we estimated counterfactual total deaths using historical data (2014–2019) of all-cause mortality by race/ethnicity. Estimates were compared to pandemic mortality trends (January 2020 to January 2021) to predict excess deaths during the pandemic for each race/ethnic group.

Results

Our findings show a significant disparity among minority excess deaths, including 7892 (24.6% increase), 4903 (20.4%), 30,186 (47.7%), and 22,027 (12.6%) excess deaths, including deaths identified as COVID-19-related, for Asian, Black, Hispanic, and White non-Hispanic individuals, respectively. Estimated increases in all-cause deaths excluding COVID-19 deaths were 1331, 1436, 3009, and 5194 for Asian, Black, Hispanic, and White non-Hispanic individuals, respectively. However, the rate of excess deaths excluding COVID-19 recorded deaths per 100 k was disproportionately high for Black (66 per 100 k) compared to White non-Hispanic (36 per 100 k). The rates for Asians and Hispanics were 23 and 19 per 100 k.

Conclusions

Our findings emphasize the importance of targeted policies for minority populations to lessen the disproportionate impact of COVID-19 on their communities.

Keywords: COVID-19, Excess mortality, Population health, Healthcare disparity

Introduction

California, the second most racially and ethnically diverse state in the US [1], was the first state to issue mandatory stay-at-home orders to mitigate COVID-19 community spread [2]. Despite this, as of July 31, 2021, the total number of COVID-19 attributed deaths passed 63,935 (163 per 100 k people), with substantial race/ethnic differences [3]. Officially reported COVID-19 deaths of Hispanics accounted for 46% of COVID-19 deaths, and Black and Hispanic individuals experienced the highest per capita deaths [3]. However, these numbers might not reveal the full impact of COVID-19 on mortality and race/ethnic disparities due to undercounting of COVID-19 deaths [46]. It is critical for the public health and surveillance system to have an accurate picture of the differential impact of the pandemic for targeted mitigation measures. Estimating excess deaths during the pandemic reveals the severity of COVID-19 for the public health system and for race/ethnic communities.

Although prior research quantified the number of excess deaths occurring during the pandemic compared to pre-pandemic mortality trends [616], few studies have examined excess deaths stratified by race/ethnicity [5, 1116]. We use Seasonal Autoregressive Integrated Moving Average (SARIMA) time series modeling to analyze pre-pandemic vs. pandemic trends in mortality stratified by race/ethnicity. Thus, we estimate the counterfactual number of deaths based on historical trends in mortality for each race/ethnic group and predict the numbers of excess deaths. Finally, we compare excess deaths with officially reported deaths from COVID-19 by race/ethnicity.

Methods

Study Setting, Data, and Design

We used monthly mortality data for race/ethnicities in California to undertake time series analyses in order to estimate total all-cause excess deaths due to the pandemic. Data on monthly total all-cause recorded deaths and officially reported COVID-19 mortality data for different races/ethnicities are from the Centers for Disease Control and Prevention (CDC) [17].

Using time series model estimates, we calculated differences between forecasted monthly deaths and total all-cause recorded deaths (excluding COVID-19) from January 2020 to January 2021 to gauge excess deaths for each group.

Statistical Analysis

We employed the Seasonal Autoregressive Integrated Moving Average (SARIMA) model, which has been used to analyze excess COVID-19 deaths in prior research [6]. Historical mortality trends from 2014 to 2019 were used to find the most predictive combination of seasonal autoregressive and seasonal moving average parameters. The SARIMA model produces reliable and accurate forecasting when there are seasonality patterns within the data (see the Appendix). Seasonality, randomness, and time trend are general causes of serial correlation and non-stationarity in time series. Using non-stationary time series produces spurious results, and serial correlation alters the efficiency of estimators. This makes SARIMA a proper choice in comparison with alternative methods.

Data were divided into training (2014–2018) and testing (2019) datasets for out-sample forecasting. Afterward, the model was used to predict excess mortality from January 2020 (when the 1st COVID-19 cases in California were identified) to January 2021. These predicted deaths were compared to all-cause mortality and official COVID-19-related deaths for each race/ethnic group. We calculate the number of deaths per 100,000 population for each race/ethnic group. All analyses used Rstudio (Version 1.4.1717-R 4.0.4) and Stata SE 15.1 (College Station, TX).

Results

The SARIMA model specification was determined based on multiple criteria (see Tables 1, 2345 and 6) and Figs. 123 and 4). Our model’s prediction shows that total all-cause deaths among race/ethnic groups were higher than expected from 2020 to 2021 (Tables 178 and 9). Recorded all-cause deaths of Hispanics (93,424) exceeded predicted deaths (63,238 (95% confidence interval (CI) 59,198–67,277)) by 30,186 excess deaths—a difference of 47.7%. 27,177 deaths of the excess deaths were COVID-19 officially reported deaths. Excluding COVID-19 deaths of Hispanics, this implies 3009 all-cause deaths, or 10% of the Hispanic excess deaths, may have occurred as a result of the pandemic (compared to historical trends) and were not recorded as COVID-19 deaths. Blacks experienced 28,993 recorded all-cause deaths, which are 4903 (20.4%) higher than predicted deaths (24,090 (95%CI 21,988–26,193)). This means that 1436 all-cause deaths (29.3% of Black excess deaths) occurred above the recorded COVID-19 deaths for Blacks. Recorded all-cause deaths of Asians (40,024) exceeded predicted deaths (32,130 (95%CI 28,884–35,383)) by 7894 (24.6%) excess deaths, resulting in 1331 all-cause deaths (16.8% of the Asian excess deaths) after we exclude recorded COVID-19 deaths of Asians. Finally, comparing the predicted deaths (174,400 (95%CI 160,946–187,853)) for White non-Hispanics with recorded all-cause deaths (196,427) reveals that there were 22,027 (12.6%) excess deaths (Table 10). Hence, there were 5194 all-cause deaths (23.6% of White non-Hispanic excess deaths) after excluding official COVID-19 deaths of White non-Hispanics. Adjusting for population size, Black individuals had the highest rate of excess deaths per 100 K people (226) followed by Hispanic (194), White non-Hispanic (153), and Asian (136). Increases in all-cause deaths (excluding COVID-19 deaths) per 100 K people were 23, 66, 19, and 36 for Asian, Black, Hispanic, and White non-Hispanic individuals, respectively (Figs. 567 and 8).

Table 1.

Model results for predicted deaths, total recorded deaths, and COVID-19-related deaths stratified by race/ethnicity

Deaths Asian Black Hispanic White non-Hispanic Total*
Total all-cause recorded deaths 40,024 28,993 93,424 196,427 358,868
SARIMA predicted deaths based on pre-COVID-19 data 32,130 24,090 63,238 174,400 293,860
Confidence interval (95%) (upper band–lower band) (28,884–35,383) (21,988–26,193) (59,198–67,277) (160,946–187,853)
Excess deaths
Number 7,892 4,903 30,186 22,027 65,008
Percentage 24.6 20.4 47.7 12.6 22.1
Per 100 K people 136 226 194 153 172
Official reported COVID-19 deaths, no
Number 6,563 3,467 27,177 16,833 54,040
Percentage of excess deaths 83.2 70.7 90 76.4 83.1
Per 100 K people 113 160 174 117 143
Estimated change in all-cause deaths excluding COVID-19 deaths
Number 1,331 1,436 3,009 5,194 10,970
Percentage of excess deaths 16.8 29.3 10 23.6 16.9
Per 100 K people 23 66 19 36 29

*We summed the numbers for race/ethnic groups, which account for 96% of the California population

Table 2.

Results of criterion and criteria of forecasting accuracy to select the best model

Asian
Model AIC BIC MSE MAPE
SARIMA(1,1,0)(2,1,0)12 587.38 596.64 22,710.69 4.91%
SARIMA(1,1,1)(2,1,0)12 570.77 581.87 19,931.24 4.31%
SARIMA(1,1,0)(1,1,0)12 590.95 598.35 22,724.77 4.85%
SARIMA(1,1,0)(2,1,1)12 588.87 599.97 19,931.24 4.31%
SARIMA(1,1,1)(1,1,1)12 588.87 599.97 22,717.52 4.93%
SARIMA(1,1,1)(2,1,1)12 572.77 585.72 19,942.12 4.31%
SARIMA(1,1,0)(3,1,0)12 588.84 599.94 22,713.46 4.93%
SARIMA(0,1,1)(2,1,0)12* 569.35 578.60 19,366.69 4.29%
SARIMA(0,1,1)(2,1,1)12 571.33 582.43 19,374.74 4.29%

AIC Akaike’s information criterion, BIC Bayesian information criterion, MSE mean square of errors, MAPE mean absolute percentage error. *Selected model

Table 3.

Results of criterion and criteria of forecasting accuracy to select the best model

Black
Model AIC BIC MSE MAPE
SARIMA(1,1,0)(2,1,0)12* 542.62 551.87 8,103.37 4.65%
SARIMA(1,1,0)(1,1,0)12 553.56 560.96 8,163.95 4.67%
SARIMA(1,1,0)(2,1,1)12 544.43 555.54 8,345.04 5.06%
SARIMA(1,1,1)(1,1,1)12 544.43 555.54 8,110.88 4.66%
SARIMA(1,1,0)(3,1,0)12 544.43 565.54 8,116.18 4.76%

AIC Akaike’s information criterion, BIC Bayesian information criterion, MSE mean square of errors, MAPE mean absolute percentage error. *Selected model

Table 4.

Results of criterion and criteria of forecasting accuracy to select the best model

Hispanic
Model AIC BIC MSE MAPE
SARIMA(1,1,0)(2,1,0)12 608.66 617.92 44,700.96 3.58%
SARIMA(1,1,1)(2,1,0)12* 600.44 611.54 49,951.90 4.17%
SARIMA(1,1,0)(1,1,0)12 618.41 625.81 45,315.21 3.62%
SARIMA(1,1,0)(2,1,1)12 610.66 621.76 49,951.90 4.17%
SARIMA(1,1,1)(1,1,1)12 610.66 621.76 44,679.52 3.58%
SARIMA(1,1,1)(2,1,1)12 602.05 615.00 51,095.09 4.24%
SARIMA(1,1,0)(3,1,0)12 610.66 621.76 44,679.92 3.58%
SARIMA(2,1,0)(2,1,2)12 609.14 623.94 49,835.44 3.75%
SARIMA(3,1,0)(3,1,0)12 605.50 620.30 52,796.08 3.85%

AIC Akaike’s information criterion, BIC Bayesian information criterion, MSE mean square of errors, MAPE mean absolute percentage error. *Selected model

Table 5.

Results of criterion and criteria of forecasting accuracy to select the best model

White non-Hispanic
Model AIC BIC MSE MAPE
SARIMA(1,1,0)(2,1,0)12* 726.78 736.03 692,464.45 4.14%
SARIMA(1,1,0)(1,1,0)12 731.23 738.63 688,284.86 4.22%
SARIMA(1,1,0)(2,1,1)12 728.10 739.20 1,107,037.37 6.79%
SARIMA(1,1,1)(1,1,1)12 728.10 739.20 694,884.74 4.14%
SARIMA(1,1,1)(2,1,1)12 717.68 730.63 1,106,587.07 6.79%
SARIMA(1,1,0)(3,1,0)12 728.04 739.14 694,770.31 4.14%

AIC Akaike’s information criterion, BIC Bayesian information criterion, MSE mean square of errors, MAPE mean absolute percentage error. *Selected Model

Table 6.

Results of SARIMA regression models

SARIMA Model Coef P > z [95% conf. interval]
Asian
MA(1)  − 1.00 1.0  − 2750.84 2748.84
Seasonality AR(1)  − 0.77  < 0.01  − 1.19  − 0.35
Seasonality AR(2)  − 0.40 0.09  − 0.85 0.06
Black
AR(1)  − 0.51  < 0.01  − 0.83  − 0.18
Seasonality AR(1)  − 0.67  < 0.01  − 0.94  − 0.40
Seasonality AR(2)  − 0.64  < 0.01  − 0.92  − 0.36
Hispanic
AR(1) 0.12 0.45  − 0.19 0.44
MA(1)  − 0.98 1.00  − 1001.20 999.20
Seasonality AR(1)  − 0.43 0.01  − 0.73  − 0.13
Seasonality AR(2)  − 0.60  < 0.01  − 0.85  − 0.34
White non-Hispanic
AR(1)  − 0.41 0.00  − 0.65  − 0.17
Seasonality AR(1)  − 0.26 0.04  − 0.51  − 0.02
Seasonality AR(2)  − 0.53  < 0.01  − 0.89  − 0.17

AR autoregressive, MA moving average; 1: first lag of the variable and 2: second lag of the variable

Fig. 1.

Fig. 1

Asian monthly total all-cause recorded deaths, SARIMA predicted deaths and officially reported COVID-19 deaths in California. Bounds denote 95% confidence intervals for forecasts

Fig. 2.

Fig. 2

Hispanic monthly total all-cause recorded deaths, SARIMA predicted deaths and officially reported COVID-19 deaths in California. Bounds denote 95% confidence intervals for forecasts

Fig. 3.

Fig. 3

White non-Hispanic monthly total all-cause recorded deaths, SARIMA predicted deaths and officially reported COVID-19 deaths in California. Bounds denote 95% confidence intervals for forecasts

Fig. 4.

Fig. 4

Black monthly total all-cause recorded deaths, SARIMA predicted deaths and officially reported COVID-19 deaths in California. Bounds denote 95% confidence intervals for forecasts

Table 7.

Results of out-of-sample (January 2020 to January 2021) predicted numbers of deaths during the pandemic from the SARIMA model—Asian

Asian [95% prediction interval]
Month Recorded Predicted Lower bound Upper bound
2020M01 2711 2730 2534 2926
2020M02 2612 2599 2336 2862
2020M03 2764 2724 2451 2997
2020M04 2870 2430 2181 2679
2020M05 2670 2398 2152 2645
2020M06 2495 2237 2004 2471
2020M07 2630 2239 2006 2473
2020M08 2818 2244 2010 2478
2020M09 2627 2147 1917 2378
2020M10 2563 2409 2162 2656
2020M11 2817 2386 2141 2631
2020M12 4749 2720 2447 2993
2021M01 5698 2869 2543 3194

AR autoregressive, MA moving average; 1: first lag of the variable and 2: second lag of the variable

Table 8.

Results of out-of-sample (January 2020 to January 2021) predicted numbers of deaths during the pandemic from the SARIMA model—Black

Black [95% prediction interval]
Month Recorded Predicted Lower bound Upper bound
2020M01 2022 2044 1882 2207
2020M02 1846 1813 1663 1963
2020M03 2030 2000 1820 2181
2020M04 2219 1803 1649 1956
2020M05 2044 1818 1662 1974
2020M06 1926 1794 1642 1947
2020M07 2178 1739 1594 1883
2020M08 2266 1645 1502 1789
2020M09 1990 1690 1552 1827
2020M10 1969 1787 1636 1938
2020M11 2018 1834 1676 1993
2020M12 3071 2007 1824 2190
2021M01 3414 2116 1886 2345

AR autoregressive, MA moving average, 1 first lag of the variable and 2 s lag of the variable

Table 9.

Results of out-of-sample (January 2020 to January 2021) predicted numbers of deaths during the pandemic from the SARIMA model—Hispanic

Hispanic [95% prediction interval]
Month Recorded Predicted Lower bound Upper bound
2020M01 5461 5401 5140 5663
2020M02 4924 4823 4510 5135
2020M03 5161 5179 4847 5512
2020M04 5656 4719 4411 5027
2020M05 5943 4853 4538 5168
2020M06 5973 4614 4311 4916
2020M07 7302 4431 4139 4723
2020M08 7110 4614 4311 4916
2020M09 5903 4533 4235 4831
2020M10 5668 4690 4384 4997
2020M11 6396 4646 4342 4950
2020M12 12,118 5171 4839 5504
2021M01 15,809 5563 5191 5935

AR autoregressive, MA moving average; 1: first lag of the variable and 2: second lag of the variable

Table 10.

Results of out-of-sample (January 2020 to January 2021) predicted numbers of deaths during the pandemic from the SARIMA model—White non-Hispanic

White non-Hispanic [95% Prediction Interval]
Month Recorded Predicted Lower Bound Upper Bound
2020M01 14,981 14,859 13,876 15,841
2020M02 13,868 13,617 12,630 14,604
2020M03 14,533 14,772 13,702 15,842
2020M04 14,226 13,304 12,297 14,312
2020M05 13,674 13,241 12,229 14,253
2020M06 12,951 12,739 11,696 13,782
2020M07 14,527 12,779 11,738 13,820
2020M08 14,676 12,351 11,284 13,418
2020M09 13,354 12,083 10,999 13,166
2020M10 13,671 13,112 12,091 14,132
2020M11 14,536 13,007 11,981 14,034
2020M12 19,870 13,979 12,955 15,003
2021M01 21,560 14,557 13,468 15,646

AR autoregressive, MA moving average; 1: first lag of the variable and 2: second lag of the variable

Fig. 5.

Fig. 5

Autocorrelation function (ACF) (left) and partial autocorrelation (PACF) correlogram (right) for first difference of time series—Asian

Fig. 6.

Fig. 6

Autocorrelation function (ACF) (Left) and partial autocorrelation (PACF) correlogram (right) for first difference of time series—Black

Fig. 7.

Fig. 7

Autocorrelation function (ACF) (left) and partial autocorrelation (PACF) correlogram (right) for first difference of time series—Hispanic

Fig. 8.

Fig. 8

Autocorrelation function (ACF) (left) and partial autocorrelation (PACF) correlogram (right) for first difference of time series-White non-Hispanic

Discussion

SARIMA time series modeling suggests that excess deaths during the pandemic are substantial and disproportionately concentrated among minorities. Hispanic excess deaths were nearly 50% higher than the number of deaths that would be predicted based on pre-pandemic mortality trends. Adjusting for population size, Black individuals had the highest rate of excess deaths per 100 k people followed by Hispanics. Reasons for our findings on the substantial race/ethnic disparities in excess deaths are unclear but may be related to differences in socioeconomic status, differential exposure to risk factors (e.g., essential workers), and healthcare-related factors including implicit biases in medical treatment [14, 15, 18, 19, 20]. Education, occupation, income, social status, and political views may alter individuals’ decisions about infection and hospitalization risks, mask wearing and other precautions, and so on. For example, low-income individuals may postpone care seeking for mild symptoms due to uninsurance and lack of paid sick leave. In addition, early diagnosis of COVID-19, access to effective COVID-19 treatments, and presence of co-morbidities will affect outcomes from infection.

More research and targeted interventions are needed to increase understanding of the drivers of COVID-19 mortality and identify policy-modifiable solutions to address excess mortality for minorities residing in California. Specifically, considering excess deaths by other causes would produce informative findings regarding COVID-19 disparities in California because mortality from heart disease and other non-COVID-19 health conditions increased during the pandemic in the USA [11]. In fact, our results on all-cause deaths excluding COVID-19 deaths imply that Black individuals followed by White non-Hispanics had the highest per-capita rates. Further research is needed to examine these disparities in non-COVID-19-related causes of mortality.

Recent research on excess deaths suggests that officially reported COVID-19 deaths understate the overall impact of the pandemic on mortality [46]. Due to the importance of excess death racial disparities to making proper health equity policy making, it is critical to have a true picture of the pandemic effect on different races/ethnic groups at the state level. Several studies have considered racial and ethnic disparities in COVID-19 mortality [1116]. However, to our knowledge, there have been only two prior studies on race/ethnic disparities in mortality during the COVID-19 pandemic for the state of California. One study examining the period March to August 2020 reported 2077 excess deaths of Asians, 1882 excess deaths of Blacks, and 8439 excess deaths of Hispanics [14]. The second study on Hispanics reported 10,304 excess deaths in California for this population for the period March 1 to October 3, 2020 [5]. Our study extends this prior work in two key ways. First, we include data updated through January 2021 during which COVID-19 cases substantially increased in California, particularly from November 2020. For example, in contrast to the prior studies’ estimates of excess deaths among Hispanics, we find 30,186 excess deaths for this community. Second, we utilize SARIMA, which adjusts for seasonality effects in mortality trends, as well as avoids the non-stationary problem.

There are limitations that should be acknowledged. First, our study findings may not generalize beyond California. Second, we cannot conclude that excess deaths are directly attributable to COVID-19; these deaths may include those that are indirectly related such as disrupted or delayed treatment for critical health issues or undiagnosed health problems. Third, our model uses historical trends in mortality from 2014 to 2019. Above or below average historical periods of mortality may impact the accuracy of forecasts of mortality in 2020 and 2021.

Conclusions

Based on monthly historical trends in all-cause mortality since 2014 and using SARIMA time series modeling, our study showed significant disparities in excess mortality among race/ethnic groups, especially among Hispanic and Black individuals, compared to officially reported COVID-19 deaths. Our findings emphasize the importance of targeted policies for minority populations, such as vaccination strategies or health and social policies, to lessen the disproportionate impact of COVID-19 and future pandemics on their communities.

Appendix

Seasonal autoregressive integrated moving average (SARIMA) regression models is a subset of time series regression model which does not rely on any exogenous variable. Instead, the model employs the past value of the targeted variable to predict future value. Indeed, SARIMA is a general form of the Autoregressive Moving Average (ARMA) model. ARMA model is also the combination of two processes Autoregressive (AR) and Moving Average (MA). AR model describes a time series based on its own past value and a stochastic term. MA model presents a time series by present and past values of a stochastic term. The necessity condition of the ARMA model is stationarity of time series (mean and variance of time series constant over time). Hence, to use the ARMA model, a non-stationary time series is converted to stationary through differencing. The “I” stands for integrated and denotes the order of differencing to make the time-series stationery. To eliminate seasonal components, seasonal differencing is applied. Technically, the “SARIMA (p, d, q)(P, D, Q)S” notion is used to present different components of the SARIMA model in which p indicates the order of the autoregressive model, d and q stand for the amount of differencing and the order of the moving average part, respectively. P is the order for seasonal AR, D is seasonal differencing, Q is the order for seasonal MA, and finally, S is the time span of repeating seasonal patterns [21].

The Box-Jenkins methodology is used to find proper value for p, d, q, P, D, Q, and S. Indeed, there are four essential steps: Model Identification, Model Estimation, Model Diagnostic checking (Checking for autocorrelation), and Forecasting with the model. Practically, the first step is detecting non-stationary in time series by Augmented Dickey-Fuller unit-root test and HEGY Seasonal unit-root test, which determines the “I” and “S.” Then, the general form of process and appropriate values of p and q should be determined based on Auto Correlation Function (ACF) and Partial Auto Correlation Function (PACF) patterns. PACF measures the correlation of the values that are k periods apart after removing the correlation from intervening lags (see Figs. 5, 6, 7, and 8,). The next step is using Akaike’s information criterion, Bayesian information criterion, and criteria of forecasting accuracy to find the best model. In addition, the SARIMA coefficients should be considered carefully. Indeed, we select our models based on the following process. We give priority to AIC and BIC, which means that we select the model with the lowest AIC and BIC. However, if there are models with significantly lower MSE and MAPE we choose a model with lower MSE and MAPE. In this condition, we check the significance of SARIMA coefficients. For example, for White people, we choose the 5th model since it has the lowest AIC and BIC. However, there are models with significantly lower MSE and MAPE than the selected model. The 1st model's MAPE is 40% lower than the 5th model. Hence, based on our selection process, we choose the model with the second-lowest AIC and BIC. Moreover, we carefully checked the estimation results, and most of the coefficients were insignificant for the 1st model (see Tables 5 and 6). Forecasting the expected mortality using the selected model is the final task.

Figure 

Author Contribution

A. Habibdoust and M. Tatar: Conceptualization, Methodology, Software, Data curation. A. Habibdoust: Writing—Original draft preparation. A. Habibdoust and M. Tatar: Visualization, Investigation. F. Wilson: Supervision. M. Tatar and F. Wilson: Writing—Reviewing and Editing.

Data Availability

The data that support the findings of this study are openly available in Tracking COVID-19 in California website at:, reference number [3].

Code Availability

Codes are available on request.

Declarations

Ethics Approval

No patients and the public were involved in this research, and the article does not involve human participants and does not contain personal medical information.

Consent to Participate

No patients and the public were involved in this research, and the article does not involve human participants and does not contain personal medical information.

Consent for Publication

No patients and the public were involved in this research, and the article does not involve human participants and does not contain personal medical information.

Competing Interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Amir Habibdoust, Email: amir.habibdoost@gmail.com.

Moosa Tatar, Email: tatarm@ccf.org.

Fernando A. Wilson, Email: fernando.wilson@utah.edu

References

  • 1.PolicyLink and the USC Equity Research Institute; National Equity Atlas, www.nationalequityatlas.org, 2020.
  • 2.Moreland A, Herlihy C, Tynan MA, Sunshine G, McCord RF, Hilton C, Poovey J, Werner AK, Jones CD, Fulmer EB, Gundlapalli AV, Strosnider H, Potvien A, García MC, Honeycutt S, Baldwin G; CDC Public Health Law Program; CDC COVID-19 Response Team, Mitigation Policy Analysis Unit. Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement - United States MMWR Morb Mortal Wkly Rep. 2020 6935:1198–1203 10.15585/mmwr.mm6935a2. [DOI] [PMC free article] [PubMed]
  • 3.Tracking COVID-19 in California. State of California – COVID19.ca.gov. URL: https://covid19.ca.gov/state-dashboard/ [accessed 2021–07–31].
  • 4.New York City Department of Health and Mental Hygiene (DOHMH) COVID-19 Response Team. Preliminary estimate of excess mortality during the COVID-19 outbreak - New York City, March 11-May 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(19):603–605 10.15585/mmwr.mm6919e5. [DOI] [PubMed]
  • 5.Chen YH, Glymour MM, Catalano R, Fernandez A, Nguyen T, Kushel M, Bibbins-Domingo K. Excess Mortality in California during the coronavirus disease 2019 pandemic, March to August 2020. JAMA Intern Med. 2021;181(5):705–707. doi: 10.1001/jamainternmed.2020.7578.PMID:33346804;PMCID:PMC7754079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tatar M, Habibdoust A, Wilson FA. Analysis of excess deaths during the COVID-19 pandemic in the state of Florida. Am J Public Health. 2021 (4):704–707 10.2105/AJPH.2020.306130. [DOI] [PMC free article] [PubMed]
  • 7.Rivera, R., Rosenbaum, J. E., & Quispe, W. (2020). Excess mortality in the United States during the first three months of the COVID-19 pandemic. Epidemiology and Infection, 148. [DOI] [PMC free article] [PubMed]
  • 8.Weinberger DM, Chen J, Cohen T, Crawford FW, Mostashari F, Olson D, ... & Viboud C. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020. JAMA internal medicine. 2020;180(10), 1336-1344. [DOI] [PMC free article] [PubMed]
  • 9.Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L. Excess deaths from COVID-19 and other causes, March-April 2020. JAMA. 2020;324(5):510–3. doi: 10.1001/jama.2020.11787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Heuveline P. The COVID-19 pandemic adds another 200,000 deaths (50%) to the annual toll of excess mortsality in the United States. Proceedings of the National Academy of Sciences. 2021 118(36). [DOI] [PMC free article] [PubMed]
  • 11.Woolf SH, Chapman DA, Sabo RT, Zimmerman EB. Excess deaths from COVID-19 and other causes in the US, March 1, 2020, to January 2, 2021. JAMA. 2021;325(17):1786–1789. doi: 10.1001/jama.2021.5199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Stokes AC, Lundberg DJ, Elo IT, Hempstead K, Bor J, Preston SH. COVID-19 and excess mortality in the United States: a county-level analysis. PLoS Med. 2021;18(5):e1003571. doi: 10.1371/journal.pmed.1003571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rossen LM, Branum AM, Ahmad FB, Sutton P, Anderson RN. Excess deaths associated with COVID-19, by age and race and ethnicity - United States, January 26-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(42):1522–7. doi: 10.15585/mmwr.mm6942e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Riley AR, Chen YH, Matthay EC, Glymour MM, Torres JM, Fernandez A, Bibbins-Domingo K. Excess mortality among Latino people in California during the COVID-19 pandemic. SSM-population health. 2021;15:100860. doi: 10.1016/j.ssmph.2021.100860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Quast T, Andel R. Excess mortality associated with COVID-19 by demographic group: evidence from Florida and Ohio. Public Health Rep. 2021;136(6):782–790. doi: 10.1177/00333549211041550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cronin CJ, & Evans WN. Excess mortality from COVID and non-COVID causes in minority populations. Proceedings of the National Academy of Sciences. 2021;118(39). [DOI] [PMC free article] [PubMed]
  • 17.Centers for Disease Control and Prevention (CDC), COVID-19 case surveillance restricted access detailed data. Updated June 15, 2021 [Accessed June 15, 2021].
  • 18.Owen, D. Covid-19: Black people and other minorities are hardest hit in US. BMJ 2020:369:1483. 10.1136/bmj.m1483. [DOI] [PubMed]
  • 19.Alsan M, Chandra A, Simon K. The Great Unequalizer: Initial Health Effects of COVID-19 in the United States. Journal of Economic Perspectives. 2021;35(3):25–46. doi: 10.1257/jep.35.3.25. [DOI] [Google Scholar]
  • 20.Milam Adam J., Furr-Holden Debra, Edwards-Johnson Jennifer, Webb Birgete, Patton John W., Ezekwemba Nnayereugo C., Porter Lekiesha, Davis TomMario, Chukwurah Marius, Webb Antonio J., Simon Kevin, Franck Geden, Anthony Joshua, Onuoha Gerald, Brown Italo M., Carson James T., Stephens Brent C. Are Clinicians Contributing to Excess African American COVID-19 Deaths? Unbeknownst to Them, They May Be. Health Equity. 2020;4(1):139–141. doi: 10.1089/heq.2020.0015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Brockwell, P. J., & Davis, R. A. Time series: theory and methods. Springer Science & Business Media. 2009

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are openly available in Tracking COVID-19 in California website at:, reference number [3].

Codes are available on request.


Articles from Journal of Racial and Ethnic Health Disparities are provided here courtesy of Nature Publishing Group

RESOURCES